Skip to main content

Table 3 Burden Assessment Scale,a Paliperidone Palmitate Group

From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

  Baseline Week 9 Week 25
All patients (observed cases)
 Total score, patients, n 96 46 33
  Mean (SD) 38.9 (14.4) 31.3 (13.0) 31.5 (13.0)
  Change from baseline, mean (SD) −8.8 (11.9) −9.2 (14.6)
Patients who completed 25 weeks of treatmentb
 Total score, patients, n 33 31 33
  Mean (SD) 40.6 (13.5) 30.6 (13.2) 31.5 (13.0)
  Change from baseline, mean (SD) −9.9 (13.2) −9.2 (14.6)
  1. aRange: 19–76
  2. bAll patients who had Burden Assessment Scale data at baseline and week 25